Ngā hua rapu kaituhi :: APM

1

Oral antibiotic prescribing during pregnancy in primary care: UK population-based study mā Irene Petersen, Ruth Gilbert, Stephen Evans, Antonia Ridolfi, Irwin Nazareth

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast cancer: a meta-analysis of published clinical trials mā Mirko Fillbrunn, James Signorovitch, Fabrice André, Iris Wang, Inés Lorenzo, Antonia Ridolfi, Jinhee Park, Akanksha Dua, Hope S. Rugo

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma mā John J. Bissler, David Neal Franz, Michael Frost, Е. Д. Белоусова, E. Martina Bebin, Steven Sparagana, Noah Berkowitz, Antonia Ridolfi, J.C. Kingswood

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2 mā John J. Bissler, Klemens Budde, Matthias Sauter, David Neal Franz, Bernard A. Zonnenberg, Michael Frost, Е. Д. Белоусова, Noah Berkowitz, Antonia Ridolfi, J.C. Kingswood

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

BOLERO-4: Phase 2 trial of first-line everolimus (EVE) plus letrozole (LET) in estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2-) advanced... mā Melanie Royce, Christian Villanueva, Mustafa Özgüroğlu, Thomas Bachelot, Sérgio Jobim Azevedo, F. Melo Cruz, Roberto Hegg, Marc Debled, WJ Gradishar, C. Manlius, Antonia Ridolfi, Jaw‐Town Lin, François Ringeisen, Fátima Cardoso

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS) mā Guillaume Canaud, Juan Carlos López‐Gutiérrez, Alan D. Irvine, P. Vabres, Jordan R. Hansford, Nii Ankrah, Fabrice Branle, Athanasia Papadimitriou, Antonia Ridolfi, P.R. O'Connell, Stuart Turner, Denise M. Adams

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Everolimus (EVE) + letrozole (LET) in patients (pts) with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC):... mā Thomas Bachelot, Melanie Royce, Christian Villanueva, F. Melo Cruz, Roberto Hegg, Carla I. Falkson, Joon Jeong, Vichien Srimuninnimit, Christina Arce, Antonia Ridolfi, Chinjune Lin, William J. Gradishar, Mustafa Özgüroğlu, Fátima Cardoso, Sérgio Jobim Azevedo

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer mā Melanie Royce, Thomas Bachelot, Cristian Villanueva, Mustafa Özgüroğlu, Sérgio Jobim Azevedo, Felipe Melo Cruz, Marc Debled, Roberto Hegg, Tatsuya Toyama, Carla I. Falkson, Joon Jeong, Vichien Srimuninnimit, William J. Gradishar, Christina Arce, Antonia Ridolfi, Chinjune Lin, Fátima Cardoso

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer mā Howard A. Burris, Arlene Chan, Aditya Bardia, J. Thaddeus Beck, Joohyuk Sohn, Patrick Neven, Debu Tripathy, Seock‐Ah Im, Stephen Chia, Francisco J. Esteva, Lowell L. Hart, Juan Pablo Zarate, Antonia Ridolfi, Karen Rodriguez Lorenc, Denise A. Yardley

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis mā Nicola Fazio, Roberto Buzzoni, Gianfranco Delle Fave, Margot Tesselaar, Edward M. Wolin, Eric Van Cutsem, Paola Tomassetti, Jonathan Strosberg, Maurizio Voi, Lida Bubuteishvili‐Pacaud, Antonia Ridolfi, Fabian Herbst, Jiří Tomášek, Simron Singh, Marianne Pavel, Matthew H. Kulke, Juan W. Valle, James C. Yao

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: